MTOR and systemic lupus erythematosus: Our data support a model in which Rab4A overexpression in SLE T cells enhances CD38 recycling and surface retention, leading to mTOR activation via traffic to the lysosome, where mTOR gets activated by sensing amino acid sufficiency.